Lazzarotto, T, Lanari, M. Why is cytomegalovirus the most frequent cause of congenital infection?
Expert Rev Anti Infect Ther. 2011; 9, 841–843.
Gajendra, S, Kumar, JV. Oral health and pregnancy: a review. N Y State Dent J. 2004; 70, 40–44.
Hasegawa, K, Furuichi, Y, Shimotsu, A, et al. . Associations between systemic status, periodontal status, serum cytokine levels, and delivery outcomes in pregnant women with a diagnosis of threatened premature labor. J Periodontol. 2003; 74, 1764–1770.
Friese, K. The role of infection in preterm labour. Br J Obstet Gynaecol. 2003; 110(Suppl. 20), 52–54.
Carta, G, Persia, G, Falciglia, K, Iovenitti, P. Periodontal disease and poor obstetrical outcome. Clin Exp Obstet Gynecol. 2004; 31, 47–49.
Spinillo, A, Capuzzo, E, Stronati, M, et al. . Obstetric risk factors for periventricular leukomalacia among preterm infants. Br J Obstet Gynaecol. 1998; 105, 865–871.
Blackwell, TS, Christman, JW. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol. 1997; 17, 3–9.
Leitich, H, Bodner-Adler, B, Brunbauer, M, et al. . Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 2003; 189, 139–147.
Mednick, SA, Machon, RA, Huttunen, MO, Bonett, D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry. 1988; 45, 189–192.
Ebert, T, Kotler, M. Prenatal exposure to influenza and the risk of subsequent development of schizophrenia. Isr Med Assoc J. 2005; 7, 35–38.
Brown, AS, Derkits, EJ. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry. 2010; 167, 261–280.
Atladottir, HO, Thorsen, P, Ostergaard, L, et al. . Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord. 2010; 40, 1423–1430.
Chess, S. Follow-up report on autism in congenital rubella. J Autism Child Schizophr. 1977; 7, 69–81.
Meyer, U, Murray, PJ, Urwyler, A, et al. . Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry. 2008; 13, 208–221.
Polivka, BJ, Nickel, JT, Wilkins, JR III. Urinary tract infection during pregnancy: a risk factor for cerebral palsy?
J Obstet Gynecol Neonatal Nurs. 1997; 26, 405–413.
Murphy, DJ, Sellers, S, MacKenzie, IZ, Yudkin, PL, Johnson, AM. Case–control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet. 1995; 346, 1449–1454.
Yoon, BH, Jun, JK, Romero, R, et al. . Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol. 1997; 177, 19–26.
Beloosesky, R, Weiner, Z, Khativ, N, et al. . Prophylactic maternal N-acetylcysteine before lipopolysaccharide suppresses fetal inflammatory cytokine responses. Am J Obstet Gynecol. 2009; 200, 665, e1-5.
Morein, B, Blomqvist, G, Hu, K. Immune responsiveness in the neonatal period. J Comp Pathol. 2007; 137(Suppl. 1), S27–S31.
Philbin, VJ, Levy, O. Developmental biology of the innate immune response: implications for neonatal and infant vaccine development. Pediatr Res. 2009; 65(5Pt 2), 98R–105R.
Immunobiology. The Immune System in Health and Disease, 5th edn, 2001. Garland Science: New York, NY.
Drake, AJ, Walker, BR, Seckl, JR. Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. Am J Physiol Regul Integr Comp Physiol. 2005; 288, R34–R38.
Beloosesky, R, Maravi, N, Weiner, Z, et al. . Maternal lipopolysaccharide-induced inflammation during pregnancy programs impaired offspring innate immune responses. Am J Obstet Gynecol. 2010; 203, 185e1–4.
Beloosesky, R, Gayle, DA, Ross, MG. Maternal N-acetylcysteine suppresses fetal inflammatory cytokine responses to maternal lipopolysaccharide. Am J Obstet Gynecol. 2006; 195, 1053–1057.
Awad, N, Khatib, N, Ginsberg, Y, et al. .
N-acetyl-cysteine (NAC) attenuates LPS-induced maternal and amniotic fluid oxidative stress and inflammatory responses in the preterm gestation. Am J Obstet Gynecol. 2011; 204, 450e15–20.
Aviram, M, Vaya, J. Markers for low-density lipoprotein oxidation. Methods Enzymol. 2001; 335, 244–256.
el-Saadani, M, Esterbauer, H, el-Sayed, M, et al. . A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res. 1989; 30, 627–630.
Xu, DX, Wang, H, Zhao, L, et al. . Effects of low-dose lipopolysaccharide (LPS) pretreatment on LPS-induced intra-uterine fetal death and preterm labor. Toxicology. 2007; 234, 167–175.
Chen, YH, Wang, JP, Wang, H, et al. . Lipopolysaccharide treatment downregulates the expression of the pregnane X receptor, cyp3a11 and mdr1a genes in mouse placenta. Toxicology. 2005; 211, 242–252.
Ejima, K, Koji, T, Tsuruta, D, et al. . Induction of apoptosis in placentas of pregnant mice exposed to lipopolysaccharides: possible involvement of Fas/Fas ligand system. Biol Reprod. 2000; 62, 178–185.
Paintlia, MK, Paintlia, AS, Barbosa, E, Singh, I, Singh, AK. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J Neurosci Res. 2004; 78, 347–361.
Paintlia, MK, Paintlia, AS, Contreras, MA, Singh, I, Singh, AK. Lipopolysaccharide-induced peroxisomal dysfunction exacerbates cerebral white matter injury: attenuation by N-acetyl cysteine. Exp Neurol. 2008; 210, 560–576.
Lante, F, Meunier, J, Guiramand, J, et al. . Neurodevelopmental damage after prenatal infection: role of oxidative stress in the fetal brain. Free Radic Biol Med. 2007; 42, 1231–1245.
Lante, F, Meunier, J, Guiramand, J, et al. . Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation. Hippocampus. 2008; 18, 602–609.
Fowden, AL, Giussani, DA, Forhead, AJ. Intrauterine programming of physiological systems: causes and consequences. Physiology (Bethesda). 2006; 21, 29–37.
Aviram, M. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic Res. 2000; (Suppl. 33), S85–S97.
Ross, R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999; 340, 115–126.
Ridker, PM, Cushman, M, Stampfer, MJ, Tracy, RP, Hennekens, CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998; 97, 425–428.
Ridker, PM, Glynn, RJ, Hennekens, CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998; 97, 2007–2011.
Kuller, LH, Tracy, RP, Shaten, J, Meilahn, EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case–control study. Multiple risk factor intervention trial. Am J Epidemiol. 1996; 144, 537–547.
Tracy, RP, Lemaitre, RN, Psaty, BM, et al. . Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the cardiovascular health study and the rural health promotion project. Arterioscler Thromb Vasc Biol. 1997; 17, 1121–1127.
Liuzzo, G, Biasucci, LM, Gallimore, JR, et al. . The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 1994; 331, 417–424.
Dempsey, PW, Vaidya, SA, Cheng, G. The art of war: innate and adaptive immune responses. Cell Mol Life Sci. 2003; 60, 2604–2621.
Sun, H, Koike, T, Ichikawa, T, et al. . C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am J Pathol. 2005; 167, 1139–1148.
Kushner, I, Jiang, SL, Zhang, D, Lozanski, G, Samols, D. Do post-transcriptional mechanisms participate in induction of C-reactive protein and serum amyloid A by IL-6 and IL-1?
Ann N Y Acad Sci. 1995; 762, 102–107.
Escobar-Morreale, HF, Luque-Ramirez, M, Gonzalez, F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011; 95, 1048–1058.
Wilson, AM, Ryan, MC, Boyle, AJ. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol. 2006; 106, 291–297.
Valko, M, Leibfritz, D, Moncol, J, et al. . Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39, 44–84.
Kushner, I, Rzewnicki, D, Samols, D. What does minor elevation of C-reactive protein signify?
Am J Med. 2006; 119, 166e17–28.
Kirsten, TB, de Oliveira, BP, de Oliveira, AP, et al. . Single early prenatal lipopolysaccharide exposure prevents subsequent airway inflammation response in an experimental model of asthma. Life Sci. 2011; 89, 15–19.
Desai, M, Gayle, DA, Casillas, E, Boles, J, Ross, MG. Early undernutrition attenuates the inflammatory response in adult rat offspring. J Matern Fetal Neonatal Med. 2009; 22, 571–575.